2026 @Philly AI in Biopharma Executive Summit

From drug discovery and clinical development to data science, corporate strategy, and investment, artificial intelligence is becoming a defining force in the next wave of life science innovation. For leaders working at the front line of the industry, the question is no longer whether AI matters, but how its potential can be translated into real breakthroughs for biopharma.

On 16 October 2026, SAPA-GP will convene the 2026 @Philly AI in Biopharma Executive Summit at the Science History Institute in Philadelphia — an invitation-scale gathering of roughly 100–150 industry leaders, decision-makers, and investment professionals from pharmaceutical companies, biotechnology firms, AI and data companies, and academic research, built for candid, peer-to-peer exchange rather than passive presentations. The keynote, full panel line-up, and confirmed speakers appear in the agenda and speaker sections below.